Cozzi, Andrea
Di Leo, Giovanni
Houssami, Nehmat
Gilbert, Fiona J.
Helbich, Thomas H.
Álvarez Benito, Marina
Balleyguier, Corinne
Bazzocchi, Massimo
Bult, Peter
Calabrese, Massimo
Camps Herrero, Julia
Cartia, Francesco
Cassano, Enrico
Clauser, Paola
de Lima Docema, Marcos F.
Depretto, Catherine
Dominelli, Valeria
Forrai, Gábor
Girometti, Rossano
Harms, Steven E.
Hilborne, Sarah
Ienzi, Raffaele
Lobbes, Marc B. I.
Losio, Claudio
Mann, Ritse M.
Montemezzi, Stefania
Obdeijn, Inge-Marie
Aksoy Ozcan, Umit
Pediconi, Federica
Pinker, Katja
Preibsch, Heike
Raya Povedano, José L.
Rossi Saccarelli, Carolina
Sacchetto, Daniela
Scaperrotta, Gianfranco P.
Schlooz, Margrethe
Szabó, Botond K.
Taylor, Donna B.
Ulus, Sila Ö.
Van Goethem, Mireille
Veltman, Jeroen
Weigel, Stefanie
Wenkel, Evelyn
Zuiani, Chiara
Sardanelli, Francesco http://orcid.org/0000-0001-6545-9427
Funding for this research was provided by:
Bayer
Università degli Studi di Milano
Article History
Received: 6 August 2023
Revised: 16 September 2023
Accepted: 11 October 2023
First Online: 24 November 2023
Declarations
:
: The scientific guarantor of this publication is Prof. Francesco Sardanelli, MD.
: Outside the present work, the authors declare the following relation with companies and institutions:Francesco Sardanelli declares relationships with Bayer Healthcare (consultation/speaker fees), Bracco Imaging (grant/research support), and General Electric Healthcare (speaker fee).Nehmat Houssami receives research funding via a National Breast Cancer Foundation (NBCF Australia) Breast Cancer Research Leadership Fellowship.Fiona J. Gilbert received research grants from General Electric Healthcare, GSK, and Hologic, and had research collaborations with Volpara and Bayer AG. She is an NIHR senior investigator and receives funding from the Cambridge BRC.Marc B. I. Lobbes received research grants from and is a member of the speakers’ bureau of General Electric Healthcare.Katja Pinker declares being part of speakers bureaus for the European Society of Breast Imaging (active), Bayer AG (ended), Siemens Healthineers (ended), DKD 2019 (ended), and Olea Medical (ended); consulting for Genentech, Merantix Healthcare, AURA Health Technologies, and Guerbet.Paola Clauser and Katja Pinker are part of the Scientific Editorial Board of <i>European Radiology</i>, and Rossano Girometti is Deputy Editor of <i>European Radiology</i>. As such, none of them had any role in handling this manuscript and none of them took part in the decision processes.All other authors declare that they have no conflict of interest related to the present work, and that they have nothing to disclose.
: The first three authors (A.C., G.D.L, N.H.) have significant statistical expertise.
: Written informed consent was obtained from all patients in this study, unless waived by local Ethics Committees.
: This study was approved by the Ethics Committee of the coordinating center on January 29, 2013 (Comitato Etico Ospedale San Raffaele, Milano, Italy; protocol number 2784), and thereafter by local Ethics Committees of participating centers.
: This paper is a targeted subanalysis of 1005 patients that were previously included in the main paper of the MIPA study (Sardanelli et al, European Radiology 2022; ExternalRef removed) and in the paper comparing patients with different MRI referrals (Cozzi et al, European Radiology 2023; ExternalRef removed).
: • prospective• observational• multicenter study